What is the recovery time after stem cell therapy for Complex Regional Pain Syndrome?
Recovery and risk depend on the exact product and route, so universal infusion, monitoring or return-to-activity timelines are unsafe. Trial documents should describe administration, observation, adverse-event and emergency arrangements and follow-up. A post-procedure pain flare should be clinically assessed rather than marketed as an expected sign of response.
What the evidence shows for Complex Regional Pain Syndrome
Evidence for CRPS cell therapy is very limited and does not establish efficacy. Preliminary or unpublished results, small samples and subjective outcomes cannot support a predictable pain or functional benefit. CRPS symptoms and placebo responses can vary substantially, making adequately blinded controls and long follow-up essential. No pooled response rate is published here. The registered studies and their own prespecified endpoints are listed in the registry table on this page.
Am I a candidate? → · Complex Regional Pain Syndrome: full overview → · Complex Regional Pain Syndrome cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.